Pu Chen

469 total citations
21 papers, 310 citations indexed

About

Pu Chen is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Pu Chen has authored 21 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Pu Chen's work include Immune Cell Function and Interaction (4 papers), Toxoplasma gondii Research Studies (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Pu Chen is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Toxoplasma gondii Research Studies (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Pu Chen collaborates with scholars based in China, United States and Germany. Pu Chen's co-authors include H.D. Tisdale, Robert M. Bock, Richard S. Criddle, Shaoheng He, Yangmin Ma, Bin Liu, Yan Hu, Rui Zhang, Bang Shen and Ningbo Xia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Pu Chen

19 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pu Chen China 9 140 73 58 57 31 21 310
Ameya Sinha Singapore 14 218 1.6× 53 0.7× 46 0.8× 38 0.7× 24 0.8× 16 433
Ross G. Douglas South Africa 12 160 1.1× 50 0.7× 35 0.6× 36 0.6× 20 0.6× 23 357
Ashley Hutchinson Canada 12 347 2.5× 88 1.2× 21 0.4× 62 1.1× 33 1.1× 23 670
Carla Pasquarello Switzerland 11 277 2.0× 30 0.4× 29 0.5× 52 0.9× 47 1.5× 13 466
Anubhav Srivastava Australia 9 189 1.4× 74 1.0× 64 1.1× 58 1.0× 6 0.2× 10 486
T.L. Arakaki United States 13 304 2.2× 51 0.7× 132 2.3× 155 2.7× 58 1.9× 18 613
Surya P. Manandhar United States 12 213 1.5× 33 0.5× 19 0.3× 33 0.6× 30 1.0× 22 400
Nicola Relitti Italy 12 223 1.6× 65 0.9× 27 0.5× 58 1.0× 95 3.1× 20 423
Deepa Jethwaney United States 8 137 1.0× 133 1.8× 25 0.4× 61 1.1× 7 0.2× 9 360
Carlos Madrid-Aliste United States 13 368 2.6× 34 0.5× 131 2.3× 97 1.7× 12 0.4× 19 607

Countries citing papers authored by Pu Chen

Since Specialization
Citations

This map shows the geographic impact of Pu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu Chen more than expected).

Fields of papers citing papers by Pu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu Chen. The network helps show where Pu Chen may publish in the future.

Co-authorship network of co-authors of Pu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pu Chen. A scholar is included among the top collaborators of Pu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pu Chen. Pu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Pu, et al.. (2025). Exercise and the organ-brain axis: Regulation of neurological disorders by emerging exerkines. Pharmacological Research. 219. 107913–107913.
3.
Chen, Pu, Yukun Chen, Ningbo Xia, et al.. (2024). A pyruvate transporter in the apicoplast of apicomplexan parasites. Proceedings of the National Academy of Sciences. 121(25). e2314314121–e2314314121. 6 indexed citations
4.
Sun, Yan, Shujun Sun, Pu Chen, et al.. (2024). Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis. Pharmacological Research. 202. 107113–107113. 5 indexed citations
5.
Song, Zhang, et al.. (2024). T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities. Journal of Autoimmunity. 144. 103176–103176. 9 indexed citations
6.
Chen, Pu, et al.. (2023). Key roles of amylopectin synthesis and degradation enzymes in the establishment and reactivation of chronic toxoplasmosis. SHILAP Revista de lepidopterología. 3(1). 8 indexed citations
7.
Lv, Hongjun, Xueyang Deng, Pu Chen, et al.. (2023). Translocated HMGB3 is involved in papillary thyroid cancer progression by activating cytoplasmic TLR3 and transmembrane TREM1. Cell Cycle. 22(23-24). 2584–2601. 2 indexed citations
8.
Jiang, Xiumei, Pu Chen, Wenxin Niu, et al.. (2023). Preparation and evaluation of dissolving tofacitinib microneedles for effective management of rheumatoid arthritis. European Journal of Pharmaceutical Sciences. 188. 106518–106518. 15 indexed citations
9.
Chen, Dongbo, Jie Gao, Pu Chen, et al.. (2022). A signature based on NKG2D ligands to predict the recurrence of hepatocellular carcinoma after radical resection. Cancer Medicine. 12(5). 6337–6347. 4 indexed citations
10.
Chen, Pu, et al.. (2021). Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 13(7). 673–683. 15 indexed citations
11.
Wang, Xiaohua, et al.. (2020). Characterization of human peripheral blood γδ T cells in patients with sepsis. Experimental and Therapeutic Medicine. 19(6). 3698–3706. 4 indexed citations
12.
Chen, Pu, et al.. (2020). MICA polymorphisms associated with antithyroid drug‐induced agranulocytosis in the Chinese Han population. Immunity Inflammation and Disease. 8(4). 695–703. 1 indexed citations
13.
Churchill, Hywyn, Franklin Fuda, Jing Xu, et al.. (2020). Leukocyte immunoglobulin‐like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation. Cytometry Part B Clinical Cytometry. 100(4). 476–487. 14 indexed citations
14.
Ma, Yangmin, et al.. (2019). Synthesis, Antimicrobial Activity, Structure-Activity Relationship, and Molecular Docking Studies of Indole Diketopiperazine Alkaloids. Frontiers in Chemistry. 7. 837–837. 48 indexed citations
15.
Xia, Ningbo, Shu Ye, Pu Chen, et al.. (2019). Pyruvate Homeostasis as a Determinant of Parasite Growth and Metabolic Plasticity in Toxoplasma gondii. mBio. 10(3). 54 indexed citations
16.
Chen, Pu, Beili Wang, Baishen Pan, & Wei Guo. (2016). Resveratrol-4-O-D-(2′-galloyl)-glucopyranoside exerts an anticancer effect on leukemia cells via inducing apoptosis. Molecular Medicine Reports. 13(3). 2281–2286. 3 indexed citations
17.
X, Zhu, et al.. (2015). [Expression of Tim-3 on Peripheral CD56(+) NK Cells and ItsCorrelation with Liver Fibrosis in Patients withAdvanced Schistosomiasis].. PubMed. 33(5). 346–50. 3 indexed citations
18.
He, Shaoheng, et al.. (2003). Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.. PubMed. 24(9). 923–9. 33 indexed citations
20.
Tisdale, H.D., et al.. (1961). Isolation and properties of the structural protein of mitochondria. Biochemical and Biophysical Research Communications. 5(2). 109–114. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026